To assess the effect of TOP2A on VM duct formation, we further examined TOP2A expression in 141 matched pairs of NSCLC specimens of tumor origin and adjacent non-tumor tissue origin by immunohistochemistry (Fig. 6C). The gene discussed is TOP2A; the disease is non-small cell lung carcinoma.